AEOLUS PHARMACEUTICALS
| WVB Number : USA000040707 | Country : United States of America |
| SIC categorization : PHARMACEUTICAL PREPARATIONS (2834) | ISIN : N/A |
| FT categorization : HEALTH CARE (431) | |
| Company status: ACTIVE |
» Corporation Profile :
| Profile in brief: The Company, a pharmaceutical company, engages in the development of medical countermeasures against biological, chemical, and radiological weapons in the United States. |
|
| Phone : 1 949 481 9825 | Fax : 949 481 9829 |
| Chairman: : JOHN L MCMANUS | Auditor : HASKELL & WHITE LLP |
| CEO/Managing Director : JOHN L MCMANUS | |
» Company Facts
| Net Profit Margin (%) | 6.20 |
| Operating Margin (%) | 6.64 |
| Return on Assets (%) | 12.66 |
| Return on Equity (%) | -1.20 |
| Employees | 6 |
» Company Financials
| Annual (2011) | |
| Income Statement ('000 USD ) |
|
| Sales/Total Revenue | 4,821 |
| EBITDA | -3,562 |
| EBIT | 320 |
| Net Income | 299 |
| Balance Sheet ( '000 USD) |
|
| Total Current Assets | 2,258 |
| Total Assets | 2,290 |
| Current Liabilities | 2,144 |
| Total Liabilities & Debt | 25,549 |
| Total Equity | -23,259 |
| Cash & Flow ( '000 USD) |
|
| Net Income/Staring Line | 299 |
| Cash from Operating | -3,119 |
| Cash from Investing | 0 |
| Cash from Financing | 1,265 |
| Cash & Equivalent Yr End | 518 |